Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers’ Submissions to the French National Authority for Health
Crossref DOI link: https://doi.org/10.1007/s40273-016-0381-4
Published Online: 2016-01-30
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghabri, Salah
Hamers, Françoise F.
Josselin, Jean Michel
Text and Data Mining valid from 2016-01-30